Colorado State Board of Pharmacy
0

Pharmacy HOME

IMPORTANT OFFICE CLOSURE ALERT

All Division of Professions and Occupations (DPO) Offices at 1560 Broadway, Denver CO are closed to the public indefinitely effective 2pm on March 23rd, 2020. However, DPO staff is still working hard to help all customers remotely. Please contact the Division at dora_dpo_licensing@state.co.us for assistance.

Welcome to the Pharmacy Homepage

The Colorado State Board of Pharmacy regulates pharmacists, pharmacy interns, in-state and nonresident pharmacies, in-state and out-of-state prescription drug wholesalers, satellite pharmacies, specialized prescription drug outlets, other outlets, and limited licenses. The Board upholds consumer protection by licensing qualified applicants, investigating complaints, and enforcing disciplinary actions against violators of the Pharmacists, Pharmacy Business and Pharmaceuticals Act and the Board's rules.

The Board consists of five pharmacist members and two public members and works in conjunction with the Federal Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), Colorado Pharmacists Society, RxPlus Pharmacies, and the Colorado Retail Council.

Program Information

Board Members

Dmitry Kunin, Program Director

Board Members:

  • Patricia A.Evacko, PharmD, President
    Term Expires: July 1, 2022

  • Kristen Wolf, PharmD, BCSCP, Vice President
    Term Expires: July 1, 2023

  • James Hansen, RPh
    Term Expires: July 1, 2023

  • Laura Holladay Rang, RPh
    Term Expires: July 1, 2021

  • Wesley Hunter, RPh
    Term Expires: July 1, 2021

  • Casey Frank, JD, MPH
    Term Expires: July 1, 2023

  • Brian C. Gonzales, MSW, LCSW, LAC
    Term Expires: July 1, 2023

Public Notices

Stakeholder Meeting - November 2, 2020

The State Board of Pharmacy will hold a VIRTUAL Stakeholder Meeting for the Board to receive feedback on the implementation of Colorado Senate Bill 20-102 (Concerning the Requirement of Providers to provide Disclosure of Sexual Misconduct to Patients prior to Treatment), and the subsequent proposed draft rule; and revisions to Rule 17.00.00, as required by the Office of Legislative Legal Services (OLLS).

  • A copy of the Notice, SB20-102, and the Draft Rules (including the changes to Rule 17.00.00) is available for download
  • Monday, November 2, 2020, at 9:00 A.M. (MDT)
  • ATTENDANCE VIA WEBINAR ONLY: Register Here
  • Watch/Listen to the Stakeholder Meeting held on September 22, 2020

 

Permanent Rulemaking Hearing - September 17, 2020

The State Board of Pharmacy (Board) will hold a VIRTUAL Permanent Rulemaking Hearing for the Board to consider adoption of the proposed new and revised State Board of Pharmacy’s rules to provide general cleanup and updates; and implement Colorado House Bill 20-1050, Colorado House Bill 20-1061, Colorado Senate Bill 20-136, and Colorado Senate Bill 20-007.

  • Thursday, September 17, 2020, at 8:45 A.M.
  • ATTENDANCE VIA WEBINAR ONLY: Register Here
  • A copy of the Notice, HB20-1050, HB20-1061, SB20-136, SB20-007, and Draft Rules are available for download

 

Stakeholder Meeting - August 6, 2020

The State Board of Pharmacy (Board) will hold a VIRTUAL Stakeholder Meeting to receive stakeholder feedback on the proposed changes to multiple Board rules that provide general cleanup, updates, and clarity; and on the implementation of Colorado House Bill 20-1050 (HB20-1050), Colorado House Bill 20-1061 (HB20-1061), Colorado Senate Bill 20-136 (SB20-136), and Colorado Senate Bill 20-007 (SB20-007). 

  • Thursday, August 6, 2020, at 9:00 A.M.
  • ATTENDANCE VIA WEBINAR ONLY: Register Here
  • Copies of the Notice, proposed draft rules, HB20-1050, HB20-1061, SB20-136, and SB20-007 are available for download

 

Permanent Rulemaking Hearing - July 16, 2020

The State Board of Pharmacy (Board) will hold a VIRTUAL Permanent Rulemaking Hearing for the Board to consider permanently adopting Rule 30.00.00 (Temporary Suspension of State Board of Pharmacy Rules Related to Covid-19), as it relates to the COVID-19 pandemic and Executive Order D 2020 038. The Board must also consider repealing Rule 3.04.00 (Colorado Cancer Drug Repository Program) subsequent to the approval of Colorado Senate Bill 19-081, which repeals the statutory provisions and basis of Rule 3.04.00.

  • Thursday, July 16, 2020, at 8:45 AM
  • ATTENDANCE VIA WEBINAR ONLY: Register Here
  • Copies of the Notice, draft rules, and SB19-081 are available for download.
Legislative Updates
Meeting Minutes

 

Open Embed